PF-06865571
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for PF-06865571, covering 2017-08-14 to 2024-07-31. Get the full timeline:
Most recent: Clinical Trial Update: A Study in Healthy Adult Male Participants to Assess Absorption, Distribution, Metabolism and Excretion (ADME) of Radiolabeled PF-06865571. [Phase 1]